Updated on 2025/04/24

写真a

 
TAKIKAWA Masahiro
 
Organization
Graduate School of Medicine Program in Integrated Medicine Musculoskeletal and Cutaneous Medicine Assistant Professor
Undergraduate School
School of Medicine Department of Medicine
Title
Assistant Professor

Degree 3

  1. 博士(生命科学) ( 2017.1   京都大学 ) 

  2. 修士(生命科学) ( 2011.3   京都大学 ) 

  3. 学士(理学) ( 2009.3   京都大学 ) 

Research Interests 2

  1. apoptosis

  2. がん、細胞死、Hippo経路、p53

Research Areas 2

  1. Life Science / Tumor biology

  2. Life Science / Molecular biology

Research History 5

  1. Nagoya University   Graduate School of Medicine   Assistant Professor

    2025.4

      More details

    Country:Japan

  2. Tokyo University of Science   Faculty of Science and Technology Applied Biological Science   Assistant Professor

    2020.4 - 2025.3

  3. National Cancer Center

    2016.12 - 2020.3

  4. Kyoto University   Researcher

    2016.9 - 2016.12

  5. Kyoto University

    2014.4 - 2016.8

Professional Memberships 2

  1. 日本分子生物学会

    2020.4

  2. 日本癌学会

    2017.9

Awards 1

  1. Outstanding Poster Presentation

    2023.10  

 

Papers 7

  1. Extrinsic induction of apoptosis and tumor suppression via the p53-Reprimo-Hippo-YAP/TAZ-p73 pathway. Reviewed International journal Open Access

    Masahiro Takikawa, Airi Nakano, Jayaraman Krishnaraj, Yuko Tabata, Yuzo Watanabe, Atsushi Okabe, Yukiko Sakaguchi, Ryoji Fujiki, Ami Mochizuki, Tomoko Tajima, Akane Sada, Shu Matsushita, Yuichi Wakabayashi, Kimi Araki, Atsushi Kaneda, Fuyuki Ishikawa, Mahito Sadaie, Rieko Ohki

    Proceedings of the National Academy of Sciences of the United States of America   Vol. 122 ( 6 ) page: e2413126122   2025.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Tumor progression is suppressed by inherent cellular mechanisms such as apoptosis. The p53 tumor suppressor gene is the most commonly mutated gene in human cancer and plays a pivotal role in tumor suppression. RPRM is a target gene of p53 known to be involved in tumor suppression, but its molecular function has remained elusive. Here, we report that Reprimo (the protein product of RPRM) is secreted and extrinsically induces apoptosis in recipient cells. We identified FAT1, FAT4, CELSR1, CELSR2, and CELSR3, members of the protocadherin family, as receptors for Reprimo. Subsequent analyses revealed that Reprimo acts upstream of the Hippo-YAP/TAZ-p73 axis and induces apoptosis by transactivating various proapoptotic genes. In vivo analyses further support the tumor-suppressive effects of secreted Reprimo. These findings identify the p53-Reprimo-Hippo-YAP/TAZ-p73 axis as an extrinsic apoptosis pathway that plays a crucial role in tumor suppression. Our finding of the innate tumor eliminator Reprimo and the downstream pathway offers a promising avenue for the pharmacological treatment of cancer.

    DOI: 10.1073/pnas.2413126122

    Open Access

    PubMed

  2. Cytochrome <scp>P450 2J2</scp> is required for the natural compound austocystin D to elicit cancer cell toxicity Reviewed Open Access

    Yukiko Kojima, Saki Fujieda, Liya Zhou, Masahiro Takikawa, Kouji Kuramochi, Toshiki Furuya, Ayaka Mizumoto, Noritaka Kagaya, Teppei Kawahara, Kazuo Shin‐ya, Shingo Dan, Akihiro Tomida, Fuyuki Ishikawa, Mahito Sadaie

    Cancer Science     2024.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    Austocystin D is a natural compound that induces cytochrome P450 (CYP) monooxygenase‐dependent DNA damage and growth inhibition in certain cancer cell lines. Cancer cells exhibiting higher sensitivity to austocystin D often display elevated CYP2J2 expression. However, the essentiality and the role of CYP2J2 for the cytotoxicity of this compound remain unclear. In this study, we demonstrate that CYP2J2 depletion alleviates austocystin D sensitivity and DNA damage induction, while CYP2J2 overexpression enhances them. Moreover, the investigation into genes involved in austocystin D cytotoxicity identified POR and PGRMC1, positive regulators for CYP activity, and KAT7, a histone acetyltransferase. Through genetic manipulation and analysis of multiomics data, we elucidated a role for KAT7 in CYP2J2 transcriptional regulation. These findings strongly suggest that CYP2J2 is crucial for austocystin D metabolism and its subsequent cytotoxic effects. The potential use of austocystin D as a therapeutic prodrug is underscored, particularly in cancers where elevated CYP2J2 expression serves as a biomarker.

    DOI: 10.1111/cas.16289

    Open Access

  3. DHX36 maintains genomic integrity by unwinding G-quadruplexes. Reviewed International journal Open Access

    Ayaka Mizumoto, Yuta Yokoyama, Tomoichiro Miyoshi, Masahiro Takikawa, Fuyuki Ishikawa, Mahito Sadaie

    Genes to cells : devoted to molecular & cellular mechanisms   Vol. 28 ( 10 ) page: 694 - 708   2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The guanine-rich stretch of single-stranded DNA (ssDNA) forms a G-quadruplex (G4) in a fraction of genic and intergenic chromosomal regions. The probability of G4 formation increases during events causing ssDNA generation, such as transcription and replication. In turn, G4 abrogates these events, leading to DNA damage. DHX36 unwinds G4-DNA in vitro and in human cells. However, its spatial correlation with G4-DNA in vivo and its role in genome maintenance remain unclear. Here, we demonstrate a connection between DHX36 and G4-DNA and its implications for genomic integrity. The nuclear localization of DHX36 overlapped with that of G4-DNA, RNA polymerase II, and a splicing-related factor. Depletion of DHX36 resulted in accumulated DNA damage, slower cell growth, and enhanced cell growth inhibition upon treatment with a G4-stabilizing compound; DHX36 expression reversed these defects. In contrast, the reversal upon expression of DHX36 mutants that could not bind G4 was imperfect. Thus, DHX36 may suppress DNA damage by promoting the clearance of G4-DNA for cell growth and survival. Our findings deepen the understanding of G4 resolution in the maintenance of genomic integrity.

    DOI: 10.1111/gtc.13061

    Open Access

    PubMed

  4. Fission yeast Stn1 maintains stability of repetitive DNA at subtelomere and ribosomal DNA regions. Reviewed International journal Open Access

    Io Yamamoto, Hidenori Nakaoka, Masahiro Takikawa, Sanki Tashiro, Junko Kanoh, Tomoichiro Miyoshi, Fuyuki Ishikawa

    Nucleic acids research   Vol. 49 ( 18 ) page: 10465 - 10476   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Telomere binding protein Stn1 forms the CST (Cdc13/CTC1-STN1-TEN1) complex in budding yeast and mammals. Likewise, fission yeast Stn1 and Ten1 form a complex indispensable for telomere protection. We have previously reported that stn1-1, a high-temperature sensitive mutant, rapidly loses telomere DNA at the restrictive temperature due to frequent failure of replication fork progression at telomeres and subtelomeres, both containing repetitive sequences. It is unclear, however, whether Stn1 is required for maintaining other repetitive DNAs such as ribosomal DNA. In this study, we have demonstrated that stn1-1 cells, even when grown at the permissive temperature, exhibited dynamic rearrangements in the telomere-proximal regions of subtelomere and ribosomal DNA repeats. Furthermore, Rad52 and γH2A accumulation was observed at ribosomal DNA repeats in the stn1-1 mutant. The phenotypes exhibited by the stn1-1 allele were largely suppressed in the absence of Reb1, a replication fork barrier-forming protein, suggesting that Stn1 is involved in the maintenance of the arrested replication forks. Collectively, we propose that Stn1 maintains the stability of repetitive DNAs at subtelomeres and rDNA regions.

    DOI: 10.1093/nar/gkab767

    Open Access

    PubMed

  5. PHLDA1, another PHLDA family protein that inhibits Akt. Reviewed International journal Open Access

    Yu Chen, Masahiro Takikawa, Shuichi Tsutsumi, Yoko Yamaguchi, Atsushi Okabe, Mayuna Shimada, Tatsuya Kawase, Akane Sada, Issei Ezawa, Yuhei Takano, Kisaburo Nagata, Yutaka Suzuki, Kentaro Semba, Hiroyuki Aburatani, Rieko Ohki

    Cancer science   Vol. 109 ( 11 ) page: 3532 - 3542   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The PHLDA family (pleckstrin homology-like domain family) of genes consists of 3 members: PHLDA1, 2, and 3. Both PHLDA3 and PHLDA2 are phosphatidylinositol (PIP) binding proteins and function as repressors of Akt. They have tumor suppressive functions, mainly through Akt inhibition. Several reports suggest that PHLDA1 also has a tumor suppressive function; however, the precise molecular functions of PHLDA1 remain to be elucidated. Through a comprehensive screen for p53 target genes, we identified PHLDA1 as a novel p53 target, and we show that PHLDA1 has the ability to repress Akt in a manner similar to that of PHLDA3 and PHLDA2. PHLDA1 has a so-called split PH domain in which the PH domain is divided into an N-terminal (β sheets 1-3) and a C-terminal (β sheets 4-7 and an α-helix) portions. We show that the PH domain of PHLDA1 is responsible for its localization to the plasma membrane and binding to phosphatidylinositol. We also show that the function of the PH domain is essential for Akt repression. In addition, PHLDA1 expression analysis suggests that PHLDA1 has a tumor suppressive function in breast and ovarian cancers.

    DOI: 10.1111/cas.13796

    Open Access

    PubMed

  6. A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors. Reviewed International journal Open Access

    Masahiro Takikawa, Rieko Ohki

    Cancer science   Vol. 108 ( 6 ) page: 1101 - 1108   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Pancreatic neuroendocrine tumors (PanNET) are rare cancers that generally have a poor prognosis. Accurate diagnosis and proper treatment of these tumors requires a better understanding of the molecular mechanisms underlying the development of PanNET. It has been shown that the mTOR inhibitor everolimus can improve the progression-free survival of PanNET patients, suggesting that inhibition of the PI3K-Akt-mTOR pathway may suppress the progression of PanNET. PHLDA3 is a novel tumor suppressor protein that inhibits Akt activation by competition for binding to PIP3 . Our analysis of PanNET revealed frequent loss-of-heterozygosity and DNA methylation at the PHLDA3 locus, resulting in strong suppression of PHLDA3 transcription. Such alterations in the PHLDA3 gene were also frequently found in lung neuroendocrine tumors (NET), suggesting the possibility that various types of NET have in common the functional loss of the PHLDA3 gene.

    DOI: 10.1111/cas.13235

    Open Access

    PubMed

  7. Fission yeast Stn1 is crucial for semi-conservative replication at telomeres and subtelomeres. Reviewed International journal Open Access

    Masahiro Takikawa, Yusuke Tarumoto, Fuyuki Ishikawa

    Nucleic acids research   Vol. 45 ( 3 ) page: 1255 - 1269   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The CST complex is a phylogenetically conserved protein complex consisting of CTC1/Cdc13, Stn1 and Ten1 that protects telomeres on linear chromosomes. Deletion of the fission yeast homologs stn1 and ten1 results in complete telomere loss; however, the precise function of Stn1 is still largely unknown. Here, we have isolated a high-temperature sensitive stn1 allele (termed stn1-1). stn1-1 cells abruptly lost telomeric sequence almost completely at the restrictive temperature. The loss of chromosomal DNA happened without gradual telomere shortening, and extended to 30 kb from the ends of chromosomes. We found transient and modest single-stranded G-strand exposure, but did not find any evidence of checkpoint activation in stn1-1 at the restrictive temperature. When we probed neutral-neutral 2D gels for subtelomere regions, we found no Y-arc-shaped replication intermediates in cycling cells. We conclude that the loss of telomere and subtelomere DNAs in stn1-1 cells at the restrictive temperature is caused by very frequent replication fork collapses specifically in subtelomere regions. Furthermore, we identified two independent suppressor mutants of the high-temperature sensitivity of stn1-1: a multi-copy form of pmt3 and a deletion of rif1. Collectively, we propose that fission yeast Stn1 primarily safeguards the semi-conservative DNA replication at telomeres and subtelomeres.

    DOI: 10.1093/nar/gkw1176

    Open Access

    PubMed

▼display all

Books 1

  1. 論文図表を読む作法 : はじめて出会う実験&解析法も正しく解釈! : 生命科学・医学論文をスラスラ読むためのFigure事典

    牛島, 俊和, 中山, 敬一( Role: Contributor ,  第3章-8: Annexin V assay / Sub-G1 assay、第3章-9: TUNEL assay / Comet assay)

    羊土社  2022.7  ( ISBN:9784758122603

     More details

    Total pages:286p   Language:Japanese

    CiNii Books

MISC 11

  1. A novel extrinsic apoptosis pathway regulated via the p53-p53PAD7-Hippo-YAP/TAZ axis

    滝川雅大, 滝川雅大, 岡部篤史, 金田篤志, 石川冬木, 定家真人, 大木理恵子

    日本癌学会学術総会抄録集(Web)   Vol. 82nd   2023

     More details

  2. Stn1, telomeric protein, maintains the stability of repetitive sequences at rDNA and subtelomeres in fission yeast

    山本唯央, 山本唯央, 中岡秀憲, 滝川雅大, 田代三喜, 加納純子, 三好知一郎, 石川冬木

    日本分子生物学会年会プログラム・要旨集(Web)   Vol. 46th   2023

     More details

  3. Molecular mechanisms behind the cytotoxicity of the natural product AusD in osteosarcoma cells

    小島有紀子, 滝川雅大, 新家一男, 旦慎吾, 石川冬木, 定家真人

    日本癌学会学術総会抄録集(Web)   Vol. 81st   2022

     More details

  4. Secreting protein p53PAD7 inhibits cell proliferation via the Hippo signaling pathway

    滝川雅大, 滝川雅大, 岡部篤史, 金田篤志, 石川冬木, 定家真人, 大木理恵子

    日本癌学会学術総会抄録集(Web)   Vol. 79th   2020

     More details

  5. Secreting protein p53PAD7 inhibits cell proliferation via the Hippo signaling pathway

    滝川雅大, 岡部篤史, 金田篤志, 石川冬木, 大木理恵子

    日本癌学会学術総会抄録集(Web)   Vol. 78th   2019

     More details

  6. 分裂酵母Stn1はrDNA反復配列の安定性維持に重要である

    山本唯央, 滝川雅大, 石川冬木

    日本分子生物学会年会プログラム・要旨集(Web)   Vol. 42nd   2019

     More details

  7. 分泌性p53標的因子p53PAD7の新規受容体の同定と細胞増殖停止機構の解明(Identification of novel receptors for secreting protein p53PAD7 that triggers inhibition of cell proliferation)

    滝川 雅大, 石川 冬木, 大木 理恵子

    日本癌学会総会記事   Vol. 77回   page: 1302 - 1302   2018.9

     More details

    Language:English   Publisher:日本癌学会  

  8. 知られざるp53の肖像 野生型・変異型p53を標的とした抗がん剤の現状

    滝川雅大, 大木理恵子

    実験医学   Vol. 35 ( 14 )   2017

     More details

  9. 分裂酵母Stn1は複製困難な染色体領域における正常な複製に重要である

    山本唯央, 滝川雅大, 石川冬木

    日本生化学会大会(Web)   Vol. 88th   2015

     More details

  10. 染色体研究Update 新しいRPAファミリーメンバーCST

    滝川雅大, 石川冬木

    細胞工学   Vol. 34 ( 11 )   2015

     More details

  11. 分裂酵母Stn1の染色体構造維持における役割

    滝川雅大, 樽本雄介, 石川冬木

    日本分子生物学会年会プログラム・要旨集(Web)   Vol. 37th   2014

     More details

▼display all

Presentations 8

  1. 分泌性タンパク質p53PAD7とHippoシグナル経路による増殖抑制機構の解明

    滝川 雅大、松下 周、渡邉 祐三、岡部 篤史、金田 篤志、石川 冬木、大木 理恵子

    第1回日本癌学会若手の会  2020.2.11 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:静岡  

  2. Secreting protein p53PAD7 inhibits cell proliferation via the Hippo signaling pathway International conference

    滝川 雅大、岡部 篤史、金田 篤志、石川 冬木、大木 理恵子

    第78回日本癌学会学術総会  2019.9.26 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:京都  

  3. Secreting protein p53PAD7 inhibits cell proliferation via the Hippo signaling pathway International conference

    滝川 雅大、渡邉 祐三、岡部 篤史、金田 篤志、石川 冬木、定家 真人、大木 理恵子

    第79回日本癌学会学術総会  2020.10.1 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    Venue:広島  

  4. Secreting protein p53PAD7 induces apoptosis via the Hippo signaling pathway International conference

    滝川 雅大、渡邉 祐三、岡部 篤史、金田 篤志、石川 冬木、定家 真人、大木 理恵子

    第44回 日本分子生物学会年会  2021.12.2 

     More details

    Language:English   Presentation type:Poster presentation  

    Venue:横浜市・パシフィコ横浜  

  5. Extrinsic apoptosis induced by p53PAD7

    2024.9.20 

  6. Identification of novel receptors for secreting protein p53PAD7 that triggers inhibition of cell proliferation International conference

    滝川雅大、石川冬木、大木理恵子

    第77回 日本癌学会学術総会  2018.9.27 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:大阪  

  7. A novel extrinsic apoptosis pathway regulated via the p53-p53PAD7-Hippo-YAP/TAZ axis International conference

    滝川 雅大、岡部 篤史、金田 篤志、石川 冬木、定家 真人、大木 理恵子

    第82回日本癌学会学術総会  2023.9.22 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    Venue:神奈川県横浜市パシフィコ横浜  

  8. A novel extrinsic apoptosis pathway regulated via the p53-p53PAD7-Hippo-YAP/TAZ axis International conference

    滝川 雅大、岡部 篤史、金田 篤志、石川 冬木、定家 真人、大木 理恵子

    The 10th International MDM2 Workshop  2023.10.16 

     More details

    Language:English   Presentation type:Poster presentation  

    Venue:東京都中央区国立がん研究センター研究所  

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 4

  1. がん細胞の堅さを標的にした特異的アポトーシス誘導法の開発

    Grant number:25K10499  2025.4 - 2028.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    滝川 雅大

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

  2. 分泌性タンパク質p53PAD7によるアポトーシス誘導メカニズムの解明

    Grant number:22K15548  2022.4 - 2025.3

    日本学術振興会  科学研究費助成事業  若手研究

    滝川 雅大

  3. Secreting protein p53PAD7 suppresses tumor proliferation via the Hippo signaling pathway

    Grant number:19K16789  2019.4 - 2022.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Early-Career Scientists

    Takikawa Masahiro

      More details

    p53PAD7 is one of a target gene of p53. Overexpression of p53PAD7 leads to inhibition of cell proliferation but the molecular mechanisms were still unknown. We found that p53PAD7 is secreted out of the cellular membrane and that addition of recombinant p53PAD7 protein to culture media leads to inhibition of cell proliferation. Mass spectrometric analysis identified that receptor candidates includes protocadherin families that is related to Hippo signaling pathway. In this study, we analyzed changes in mRNA expression profiles in cells treated with recombinant p53PAD7. Furthermore, we investigated the effect of p53PAD7 to tumor progression in mice.

  4. Functional analysis of PHLDA3 in neuroendocrine tumor

    Grant number:17H07378  2017.8 - 2019.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity Start-up

    TAKIKAWA Masahiro

      More details

    PHLDA3 is a target gene of p53. Inactivation of PHLDA3 by loss of heterozygosity (LOH) in PHLDA3 locus is frequently observed in pancreatic and lung neuroendocrine tumors (NETs) (Cell 2009, PNAS 2014). We hypothesized that neuroendocrine tumors arisen in every organ might harbor genetic alterations in PHLDA3. To investigate the relationship between PHLDA3 alterations and cancer malignancy, we collected several kinds of clinical samples and constructed NET model mice.
    We found that PHLDA1, another PHLDA family gene, acts as a repressor for cell proliferation via competitive interaction to PIPs leading to Akt inhibition.

 

Teaching Experience (Off-campus) 2

  1. Fundamental Biology - Information Flow in Biosystem

    2020 - 2025 Tokyo University of Science)

  2. Elementary Gene Engineering

    2020 - 2025 Tokyo University of Science)